MARKET PULSE-Allergan, Marathon, GW Pharma, Medidata

Tue Apr 22, 2014 1:51pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter,

April 22 (Reuters) - U.S. stocks rose on Tuesday, with both the S&P 500 and Nasdaq on track for a sixth straight day of gains as a number of bellwether companies reported strong results. The Dow Jones industrial average was up 0.67 percent at 16,558.91, the S&P 500 was up 0.66 percent at 1,884.3 and the Nasdaq Composite was up 1.12 percent at 4,167.685.

** MARATHON PETROLEUM CORP, $90.47, +0.37 pct

Analysts at Howard Weil removed the refining company from its focus list, saying that the price differential between WTI crude and Brent crude would remain narrow in the second quarter. The narrowing spread could hurt margins for Midwest refiners, such as Marathon Petroleum, which refine cheap U.S. crude into gasoline, diesel and other products to be sold at prices linked to the more expensive Brent. Brent's premium over WTI CL-LCO1=R has averaged $8.56 so far this year, lower than last year's average spread of $10.57.

** MODINE MANUFACTURING CO, $15.9, +9.96 pct

Robert W. Baird upgraded the company' stock to "outperform" from "neutral," reported.

** TIME WARNER CABLE, $139.99, +2.48 pct   Continued...